Evidence map›Paper›PMID 33053776›Full record

ArticleBioengineering (Basel, Switzerland)2020

Encapsulation of Hydrophobic Drugs in Shell-by-Shell Coated Nanoparticles for Radio-and Chemotherapy-An In Vitro Study.

Stefanie Klein, Tobias Luchs, Andreas Leng, Luitpold V R Distel, Winfried Neuhuber, Andreas Hirsch

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Non-Covalent Postfunctionalization of Dye Layers on TiOChemistry (Weinheim an der Bergstrasse, Germany) · 2021
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Stefanie KleinDepartment of Chemistry and Pharmacy, Physical Chemistry I and ICMM, Friedrich-Alexander University of Erlangen Nuremberg, Egerlandstr. 3, D-91058 Erlangen, Germany.ORCID 0000-0003-1617-3451
Tobias LuchsDepartment of Chemistry and Pharmacy, Chair of Organic Chemistry II, Friedrich-Alexander University of Erlangen Nuremberg, Nikolaus-Fiebiger-Str. 10, D-91058 Erlangen, Germany.ORCID 0000-0002-7144-0324
Andreas LengDepartment of Chemistry and Pharmacy, Chair of Organic Chemistry II, Friedrich-Alexander University of Erlangen Nuremberg, Nikolaus-Fiebiger-Str. 10, D-91058 Erlangen, Germany.
Luitpold V R DistelDepartment of Radiation Oncology, Friedrich-Alexander University of Erlangen Nuremberg, Universitätsstr. 27, D-91054 Erlangen, Germany.ORCID 0000-0002-8040-3226
Winfried NeuhuberInstitute of Anatomy and Cell Biology, Chair of Anatomy I, Friedrich-Alexander University of Erlangen Nuremberg, Krankenhausstr. 9, D-91054 Erlangen, Germany.ORCID 0000-0003-1387-4682
Andreas HirschDepartment of Chemistry and Pharmacy, Chair of Organic Chemistry II, Friedrich-Alexander University of Erlangen Nuremberg, Nikolaus-Fiebiger-Str. 10, D-91058 Erlangen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our research objective was to develop novel drug delivery vehicles consisting of TiO

Indexed as

Al2O3 nanoparticleschemotherapydrug deliveryquercetinradiotherapyshell-by-shell nanoparticlesTiO2 nanoparticles

Identifiers

PMID33053776
PMCPMC7712138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.